Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Consolidated Net Income: 2024-2025

Historic Consolidated Net Income for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$22.0 million.

  • Pyxis Oncology's Consolidated Net Income fell 3.77% to -$22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.4 million, marking a year-over-year change of. This contributed to the annual value of -$77.3 million for FY2024, which is 4.66% down from last year.
  • Latest data reveals that Pyxis Oncology reported Consolidated Net Income of -$22.0 million as of Q3 2025, which was down 3.99% from -$21.2 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Consolidated Net Income registered a high of -$3.3 million during Q2 2024, and its lowest value of -$35.6 million during Q4 2024.
  • For the 2-year period, Pyxis Oncology's Consolidated Net Income averaged around -$18.4 million, with its median value being -$21.2 million (2024).
  • Data for Pyxis Oncology's Consolidated Net Income shows a maximum YoY crashed of 549.82% (in 2025) over the last 5 years.
  • Pyxis Oncology's Consolidated Net Income (Quarterly) stood at -$35.6 million in 2024, then decreased by 3.77% to -$22.0 million in 2025.
  • Its Consolidated Net Income was -$22.0 million in Q3 2025, compared to -$21.2 million in Q2 2025 and -$21.7 million in Q1 2025.